Evidence map›Paper›PMID 32301246›Full record

ArticleHuman brain mapping2022

ENIGMA-DTI: Translating reproducible white matter deficits into personalized vulnerability metrics in cross-diagnostic psychiatric research.

Peter Kochunov, L Elliot Hong, Emily L Dennis, Rajendra A Morey, David F Tate, Elisabeth A Wilde, Mark Logue, Sinead Kelly, Gary Donohoe, Pauline Favre and 22 more

Open access · goldAbstract read
In one paragraph

Article in Human brain mapping, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 5 pooled it
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 5 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Suicide attempts, white matter microstructure, and cognitive function in schizophrenia.European archives of psychiatry and clinical neuroscience · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Research square · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Lifespan Normative Modeling of Brain Microstructure.bioRxiv : the preprint server for biology · 2025
    Article
  17. Article
  18. Toward Big Data-Derived Classification of Neuropsychiatric Disorders.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 9 countries.

Peter KochunovMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-3656-4281
L Elliot HongMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Emily L DennisPsychiatry Neuroimaging Laboratory, Brigham & Women's Hospital, Boston, Massachusetts, USA.
Rajendra A MoreyBrain Imaging and Analysis Center, Duke University, Durham, North Carolina, USA.
David F TateDepartment of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Elisabeth A WildeDepartment of Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Mark LogueVA Boston Healthcare System, National Center for PTSD, Boston, Massachusetts, USA.
Sinead KellyImaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
Gary DonohoeCentre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.
Pauline FavreNeurospin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
Josselin HouenouNeurospin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.
Christopher R K ChingImaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
Laurena HolleranCentre for Neuroimaging and Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, National University of Ireland Galway, Galway, Ireland.
Ole A AndreassenNorwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Laura S van VelzenCentre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
Lianne SchmaalCentre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
Julio E Villalón-ReinaImaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
Carrie E BeardenDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California at Los Angeles, Los Angeles, California, USA.
Fabrizio PirasLaboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.
Gianfranco SpallettaLaboratory of Neuropsychiatry, Department of Clinical and Behavioral Neurology, IRCCS Santa Lucia Foundation, Rome, Italy.ORCID 0000-0002-7432-4249
Odile A van den HeuvelAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Dick J VeltmanAmsterdam UMC, Vrije Universiteit Amsterdam, Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Dan J SteinDepartment of Psychiatry & Neuroscience Institute, University of Cape Town, SA MRC Unit on Risk & Resilience in Mental Disorders, Cape Town, South Africa.
Meghann C RyanMaryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Yunlong TanBeijing Huilongguan Hospital, Peking University Huilongguan Clinical Medical School, Beijing, China.
Theo G M van ErpClinical Translational Neuroscience Laboratory, Department of Psychiatry, University of California Irvine, Irvine, California, USA.
Jessica A TurnerDepartment of Psychology and Neuroscience Institute, Georgia State University, Atlanta, Georgia, USA.
Liz HaddadImaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
Talia M NirImaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
David C GlahnDepartment of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Paul M ThompsonImaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
Neda JahanshadImaging Genetics Center, USC Mark and Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine of USC, Marina del Rey, California, USA.
Imaging Center · USUniversity of Maryland, Baltimore · USAmsterdam Neuroscience · NLInserm · FROllscoil na Gaillimhe – University of Galway · IEThe University of Melbourne · AUUniversity of Utah · USBaylor College of Medicine · USBoston Children's Hospital · USBoston University · USBrigham and Women's Hospital · USDuke University · USFondazione Santa Lucia · ITGeorgia State University · USHarvard University · USOslo University Hospital · NOPeking University · CNSouth African Medical Research Council · ZAUniversity of California, Irvine · USUniversity of California, Los Angeles · US

Funding

TR&D3: Intrinsic Surface MappingP41EB015922 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI VAN HORN, JOHN DARRELL · 2012 to 2022
$14.1M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
Neurodevelopment and Psychosis in the 22q11.2 Deletion SyndromeR01MH085953 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEARDEN, CARRIE E · 2010 to 2020
$6.2M
SOLAR-Eclipse Computational Tools for Imaging GeneticsR01EB015611 · NIBIB · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI KOCHUNOV, PETER V. · 2012 to 2024
$5.0M
ENIGMA-COINSTAC-APOE2 Functional and structural connectome protective mechanisms for Alzheimer’s disease and mood disorders: Request for supplemental funds for NIH R01:1R01MH121246R01MH121246 · NIMH · OHIO STATE UNIVERSITY · PI CALHOUN, VINCE D, TURNER, JESS · 2019 to 2023
$5.0M
Integrative Molecular and Phenotype Analysis of 22q11.2 Deletion SyndromeR01MH100900 · NIMH · STANFORD UNIVERSITY · PI HALLMAYER, JOACHIM F · 2013 to 2017
$4.8M
Trauma and Genomics Modulate Brain Structure across Common Psychiatric DisordersR01MH111671 · NIMH · DUKE UNIVERSITY · PI MARK W LOGUE, RAJENDRA A MOREY · 2017 to 2026
$4.4M
Amish Connectome Project on Mental IllnessU01MH108148 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI HONG, L ELLIOT ELLIOT, KOCHUNOV, PETER V. · 2015 to 2018
$4.3M
Towards Multisystem-Brain Successful Aging in Schizophrenia SpectrumR01MH116948 · NIMH · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HONG, L ELLIOT ELLIOT · 2018 to 2022
$3.7M
Lifespan Vascular Biology on White MatterRF1NS114628 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI HONG, L ELLIOT ELLIOT, KOCHUNOV, PETER V. · 2020 to 2020
$3.1M
High resolution mapping of the genetic risk for disease in the aging brainR01AG059874 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JAHANSHAD, NEDA · 2018 to 2022
$3.1M
ENIGMA Bipolar Initiative: A Global Study of Imaging Genomics & Clinical OutcomesR01MH129742 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christopher Ching, PAUL M THOMPSON · 2022 to 2026
$3.0M
BLRD VA I01 BX003477BLRD VA I01BX003477European Research Council ERC677467Health Research Board CDA-2018-001NIA NIH HHS R01 AG059874NIA NIH HHS R56 AG058854NIA NIH HHS T32 AG058507NIBIB NIH HHS P41 EB015922NIBIB NIH HHS R01 EB015611NIBIB NIH HHS U54 EB020403NIH HHS 1R01MH121246-01NIH HHS 5T32MH073526NIH HHS K99NS096116NIH HHS NIA T32AG058507NIH HHS R01 AG059874NIH HHS R01EB015611NIH HHS R01-MH111671NIH HHS R01MH111671NIH HHS R01MH112180NIH HHS R01 MH116147NIH HHS R01MH116948NIH HHS R01 NS107739NIH HHS R56 AG058854NIH HHS S10 OD023696NIH HHS S10OD023696NIH HHS U01MH108148NIH HHS U54 EB020403NIMH NIH HHS R01085953NIMH NIH HHS R01 MH085953NIMH NIH HHS R01 MH100900NIMH NIH HHS R01 MH111671NIMH NIH HHS R01 MH112180NIMH NIH HHS R01 MH116147NIMH NIH HHS R01 MH116948NIMH NIH HHS R01 MH117601NIMH NIH HHS R01MH117601NIMH NIH HHS R01 MH121246NIMH NIH HHS R01 MH129742NIMH NIH HHS R01 MH133812NIMH NIH HHS R21 MH116473NIMH NIH HHS R37 MH085953NIMH NIH HHS RF1 MH123163NIMH NIH HHS T32 MH073526NIMH NIH HHS U01 MH108148NIMH NIH HHS U01 MH119736NINDS NIH HHS K99 NS096116NINDS NIH HHS R01 NS114628NINDS NIH HHS R21 NS107739NINDS NIH HHS RF1 NS114628RRD VA I01 RX002174Science Foundation Ireland 16ERCS3787
6 · The paper itself

Abstract

The ENIGMA-DTI (diffusion tensor imaging) workgroup supports analyses that examine the effects of psychiatric, neurological, and developmental disorders on the white matter pathways of the human brain, as well as the effects of normal variation and its genetic associations. The seven ENIGMA disorder-oriented working groups used the ENIGMA-DTI workflow to derive patterns of deficits using coherent and coordinated analyses that model the disease effects across cohorts worldwide. This yielded the largest studies detailing patterns of white matter deficits in schizophrenia spectrum disorder (SSD), bipolar disorder (BD), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), posttraumatic stress disorder (PTSD), traumatic brain injury (TBI), and 22q11 deletion syndrome. These deficit patterns are informative of the underlying neurobiology and reproducible in independent cohorts. We reviewed these findings, demonstrated their reproducibility in independent cohorts, and compared the deficit patterns across illnesses. We discussed translating ENIGMA-defined deficit patterns on the level of individual subjects using a metric called the regional vulnerability index (RVI), a correlation of an individual's brain metrics with the expected pattern for a disorder. We discussed the similarity in white matter deficit patterns among SSD, BD, MDD, and OCD and provided a rationale for using this index in cross-diagnostic neuropsychiatric research. We also discussed the difference in deficit patterns between idiopathic schizophrenia and 22q11 deletion syndrome, which is used as a developmental and genetic model of schizophrenia. Together, these findings highlight the importance of collaborative large-scale research to provide robust and reproducible effects that offer insights into individual vulnerability and cross-diagnosis features.

Indexed as

Diffusion Tensor ImagingMental DisordersWhite MatterBiomedical ResearchHumansMulticenter Studies as TopicPsychiatrybig datacross-disorderDTIENIGMARVIwhite matter deficit patterns

Identifiers

PMID32301246
PMCPMC8675425
OpenAlexW3017063260

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.